Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 13/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 11/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18503611 | 0.93 | CYP11B2 (0.42) | CYP11B2CYP11B1TP53IDO1LMNA | |
| SCHEMBL18503595 | 0.90 | CYP11B2 (0.42) | CYP11B2CYP11B1TP53LMNAGAA | |
| SCHEMBL18503591 | 0.90 | TP53 (0.40) | CYP11B2TP53IDO1LMNAGAA | |
| SCHEMBL18503629 | 0.90 | LMNA (0.41) | CYP11B2CYP11B1TP53LMNAGAA | |
| SCHEMBL18503596 | 0.88 | CYP11B2 (0.60) | CYP11B2CYP11B1TP53HCRTR1HCRTR2 | |
| SCHEMBL18503604 | 0.88 | CYP11B2 (0.44) | CYP11B2CYP11B1TP53LMNAGAA | |
| SCHEMBL17713105 | 0.87 | TP53 (0.48) | TP53LMNAGAACHRM3 | |
| SCHEMBL18503600 | 0.87 | KIF11 (0.44) | CYP11B2CYP11B1TP53LMNACHRM3 | |
| SCHEMBL18503640 | 0.86 | CYP11B2 (0.43) | CYP11B2CYP11B1IDO1HCRTR1HCRTR2 | |
| SCHEMBL18503594 | 0.84 | KIF11 (0.41) | CYP11B2TP53LMNAGAACHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | BAYER ANIMAL HEALTH GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | BAYER ANIMAL HEALTH GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | ACHE, DDT, DNPH1 | CYP11B2 2963/4885CYP11B1 3138/4885TP53 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.